UK – MHRA to recognize foreign regulatory approvals for medicines and medical technologies and promote digital innovation

Last week, Jeremy Hunt, Chancellor of the Exchequer, published his Spring Budget for the UK.  It identified life sciences and digital technologies as “high growth sectors,” which the UK Government wishes to prioritise.  Among other things, the Budget outlined the Government’s plans to simplify medicines and technology approvals, plus changes to the regulation and support of digital technologies and artificial intelligence (“AI”).  Essentially, the Government wants “the UK to be the best place in Europe for companies to locate, invest and grow” and has announced plans to “strengthen [our] technology and life science sectors.”  The Government intends to support those working in these sectors through regulatory changes, as well as better infrastructure and additional funding.  This blog post summarizes some of the key announcements…